Print
Health Care

Thermo Fisher's PPD Lands National Cancer Institute Contract

By Staff Reports, posted Sep 15, 2022
The PPD clinical research business of Thermo Fisher Scientific Inc. has been awarded a 10-year contract by the National Cancer Institute (NCI), according to a news release Thursday.

The Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract supports NCI’s Cancer Trials Support Unit (CTSU).

As part of the award, the PPD clinical research business "will have the opportunity to coordinate the resources and processes necessary to identify, deploy, support and maintain a platform for the collection and migration of electronic patient-reported outcomes (ePROs) and other patient-generated health data into NCI Multi-Center Organization (MCO) clinical trials supported by CTSU," the release stated.

Thermo Fisher’s PPD clinical research business has three decades of experience delivering clinical research services to governmental agencies, contractors and nonprofits in conducting therapeutic, vaccine and medical device studies on a global scale across all trial phases and a broad array of therapeutic areas, the release stated.

“NCI’s focus on progressing cancer research across the nation is one we all support, to advance scientific knowledge and to help all people live longer, healthier lives,” said David M. Johnston, senior vice president and president of clinical research for Thermo Fisher Scientific, in the release. “The research that NCI champions is vital to improving the outcomes of patients battling this group of diseases. We are privileged to support NCI in those efforts.”

Cancer is among the leading causes of death worldwide, according to the release.

"In 2022, NCI estimates there will be more than 1.9 million new cases of cancer and more than 600,000 cancer deaths in the United States. Globally, the World Health Organization notes that nearly one in every six deaths can be attributed to cancer, with approximately 400,000 children developing cancer every year," the release stated.

The business’ team of experts providing PPD Digital and Decentralized solutions "works closely with leading research organizations around the world to navigate evolving trends in drug development, including the design and deployment of customized, remote clinical trials," according to the release, which also stated that the business "employs innovative electronic clinical outcome assessment (eCOA) technologies to enable sites, patients and customers to share data more effectively than traditional methods. In addition, eCOAs and ePROs use digital platforms to enable direct data collection from study stakeholders, resulting in less paper documentation and more timely data, with greater consistency from patients."

PPD has conducted more than 675 oncology and hematology studies in the past five years involving more than 114,000 patients at over 26,000 sites around the world.

"Those trials represent more than one-quarter of the studies the business has conducted in that time. The business’ team of experts providing PPD laboratory services helped develop 24 of the top 25 best-selling oncology drugs of 2020," the release stated.

This project will be funded in whole with federal funds from the NCI, National Institutes of Health and Department of Health and Human Services under Contract No. 75N91022D00012.
Ico insights

INSIGHTS

SPONSORS' CONTENT
Dallasromanowski headshotcopy

How to Plan When You’re Too Busy to Plan

Dallas Romanowski - Cornerstone Business Advisors
Burrus rob headshot 300x300

Forget the Diet, Bring on the Wealth

Robert Burrus - Cameron School of Business - UNC-Wilmington
Headshots march websized 2

How to Prepare Your Commercial Roof for Cooler Weather

David Grandey - Highland Roofing Company

Trending News

Avelo Airlines Extends Seasonal Offerings At ILM

Miriah Hamrick - Dec 5, 2022

More Space To Film: Dark Horse Studios Plans $20M Expansion

Cece Nunn - Dec 5, 2022

Wilmington Named As A Top City For Remote Workers In Nationwide Study

Staff Reports - Dec 6, 2022

Endowment To Announce Inaugural Grant Recipients At Friday Event

Staff Reports - Dec 5, 2022

At Chamber’s Economic Summit, Experts Talk Talent And Site Selection

Johanna F. Still - Dec 6, 2022

In The Current Issue

Retirement U-Turn

Many Cape Fear area retirees might initially opt for a life of leisure but discover that they still have a lot to give, and perhaps a lot to...


Film Festivals Make A Comeback

Area film festivals took a hit when the COVID pandemic was at its peak, but their organizers expect lessons they learned about the importanc...


Back To School At Any Age

Amy Keith returned to UNCW in 2009, this time as a program coordinator at OLLI, which focuses on lifelong learning for people 50 and older....

Book On Business

The 2022 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

Trying to Grow a Business?
2020 Health Care Heroes
2020 WilmingtonBiz 100